Tevogen Bio Holdings Inc. (TVGN) Stock Ticker
Market factors today
Unlock the full TVGN picture
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
TVGN stock facts
| Ticker symbol | TVGN |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $30.2M |
| CEO | Ryan H. Saadi |
| Employees | 18 |
| Headquarters | Warren, NJ, US |
| IPO date | 2022-01-05 |
| Website | tevogen.com |
What you can see for TVGN on Tickr
Live TVGN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TVGN report.
Rankings
FAQ
What is the ticker symbol for Tevogen Bio Holdings Inc.?
The ticker symbol for Tevogen Bio Holdings Inc. is TVGN, listed on the NASDAQ Global Market.
What is TVGN?
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long…